The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study Comparative Study
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
Previous trials have shown that among high-risk patients with aortic stenosis, survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. We evaluated the two procedures in a randomized trial involving intermediate-risk patients. ⋯ In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke. (Funded by Edwards Lifesciences; PARTNER 2 ClinicalTrials.gov number, NCT01314313.).
-
Comment Letter
Transcatheter Aortic-Valve Replacement in Clinical Practice.